Cognition Associated With Future Depression Risk - Scorecard - MDSpire

Cognition Associated With Future Depression Risk

Lower cognition is associated with later depression in controls, while higher cognition is associated with relapse in remitted depression

  • By

  • Kathryn Wighton

  • June 1, 2026

  • 4 min

Share

Clinical Scorecard: Cognition Associated With Future Depression Risk

At a Glance

CategoryDetail
Condition
Key MechanismsOmit or provide a direct source.
Target Population
Care Setting

Key Highlights

  • Remove or source the statement about higher cognitive performance in remitted depression being associated with greater future depression risk.

Guideline-Based Recommendations

Diagnosis

    Management

    • A
    • d
    • d
    • s
    • o
    • u
    • r
    • c
    • e
    • a
    • t
    • t
    • r
    • i
    • b
    • u
    • t
    • i
    • o
    • n
    • .

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Individuals with remitted depression and matched controls.

        Cognitive performance may inform future depression risk assessment.

        Clinical Best Practices

        • Evaluate cognitive performance in patients with a history of depression.

        Related Resources & Content

        Original Source(s)

        Cognition Associated With Future Depression Risk

        • by Kathryn Wighton

        • June 1, 2026

        Related Content

        Dual-Site Theta Burst Stimulation May Reduce Suicidal Ideation

        Four-day treatment targeting the prefrontal cortex and cerebellum produced larger reductions in suicidal ideation scores than prefrontal stimulation alone in adolescents with major depressive disorder.

        Neurodegenerative Mortality May Be Higher in NFL Players

        The largest study of former National Football League players found excess persisted even after accounting for the lower overall mortality associated with elite athletic participation.

        At-Home Telehealth-Supported Subcutaneous Ketamine Therapy for Safety, Feasibility, and Clinical Outcomes in Adults With Moderate to Severe Depression, Anxiety, or Posttraumatic Stress Disorder in a Large, Heterogeneous Cohort in the United States: Retrospective Cohort Study